BeiGene
BGNE
#961
Rank
$20.20 B
Marketcap
$184.71
Share price
0.49%
Change (1 day)
15.60%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company